MedPath

The effect of iron deficiency treatment on insulin resistance

Phase 3
Conditions
Condition 1: Diabetes. Condition 2: Iron deficiency anemia.
Diabetes mellitus due to underlying condition
Iron deficiency anemia
Registration Number
IRCT20170215032587N3
Lead Sponsor
Ghoum University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

More than one year has passed since the diagnosis of type 2 diabetes
Age 30-50 years
Iron deficiency anemia with hemoglobin less than 12

Exclusion Criteria

Insulin therapy
Polymenorrhea
Chronic diarrhea
History of gastrectomy
CRP above 10 mg/L
Pregnancy
Breast-feeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: Six months after beginning treatment. Method of measurement: HOMA-IR formula.;Hemoglobin A1C. Timepoint: Six months after beginning treatment. Method of measurement: Blood test, High-performance liquid chromatography.
Secondary Outcome Measures
NameTimeMethod
The level of blood triglycerides. Timepoint: Six months after beginning treatment. Method of measurement: Blood test, Enzymatic photometric test.;The level of blood cholestrol. Timepoint: Six months after beginning treatment. Method of measurement: Blood test, Enzymatic test.
© Copyright 2025. All Rights Reserved by MedPath